The study of fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant liver tumor
Not Applicable
Recruiting
- Conditions
- malignant liver tumor
- Registration Number
- JPRN-UMIN000011136
- Lead Sponsor
- Department of Surgery, Hirakata Hospital, Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who meet any of the conditions described below are excluded. 1.Patients with porphyria. 2.Patients with hypersensitivity to 5-ALA or porphyrins. 3.In cases of known or suspected pregnancy or woman who are breast-feeding. 4.In cases of hepatic insufficiency (total bilirubin >2.4mg/dL, AST>70U/L, ALT>70U/L) on post 1 and 7 days after taking 5-ALA before 2 weeks of surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method resection rate
- Secondary Outcome Measures
Name Time Method